CI Investments Inc’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $384K | Sell |
3,056
-886
| -22% | -$111K | ﹤0.01% | 572 |
|
|
2025
Q1 | $436K | Sell |
3,942
-342
| -8% | -$37.8K | ﹤0.01% | 541 |
|
|
2024
Q4 | $585K | Buy |
4,284
+738
| +21% | +$101K | ﹤0.01% | 485 |
|
|
2024
Q3 | $409K | Buy |
3,546
+879
| +33% | +$101K | ﹤0.01% | 520 |
|
|
2024
Q2 | $367K | Buy |
2,667
+29
| +1% | +$3.99K | ﹤0.01% | 521 |
|
|
2024
Q1 | $364K | Buy |
2,638
+1,174
| +80% | +$162K | ﹤0.01% | 539 |
|
|
2023
Q4 | $193K | Sell |
1,464
-270
| -16% | -$35.6K | ﹤0.01% | 654 |
|
|
2023
Q3 | $195K | Sell |
1,734
-244
| -12% | -$27.4K | ﹤0.01% | 636 |
|
|
2023
Q2 | $187K | Buy |
1,978
+1,140
| +136% | +$108K | ﹤0.01% | 644 |
|
|
2023
Q1 | $85K | Buy |
838
+697
| +494% | +$70.7K | ﹤0.01% | 774 |
|
|
2022
Q4 | $17K | Hold |
141
| – | – | ﹤0.01% | 1089 |
|
|
2022
Q3 | $15K | Sell |
141
-1
| -0.7% | -$106 | ﹤0.01% | 1070 |
|
|
2022
Q2 | $14K | Sell |
142
-332
| -70% | -$32.7K | ﹤0.01% | 1012 |
|
|
2022
Q1 | $44K | Sell |
474
-28
| -6% | -$2.6K | ﹤0.01% | 971 |
|
|
2021
Q4 | $43K | Buy |
502
+94
| +23% | +$8.05K | ﹤0.01% | 1020 |
|
|
2021
Q3 | $39K | Buy |
+408
| New | +$39K | ﹤0.01% | 999 |
|
|
2020
Q3 | – | Sell |
-3,565
| Closed | -$435K | – | 951 |
|
|
2020
Q2 | $435K | Buy |
+3,565
| New | +$435K | ﹤0.01% | 421 |
|